E. Ohman J:Or Asset Management Ab Legend Biotech Corp Transaction History

E. Ohman J:Or Asset Management Ab

  • $4.29 Trillion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 15, 2024
SELL
$57.25 - $69.74 $97,325 - $118,557
-1,700 Reduced 20.48%
6,600 $397 Million
Q3 2023

Feb 06, 2024
BUY
$63.16 - $76.5 $524,228 - $634,950
8,300 New
8,300 $558 Million
Q1 2023

Apr 05, 2024
BUY
$43.42 - $57.37 $147,628 - $195,058
3,400 Added 51.52%
10,000 $482 Million

Others Institutions Holding LEGN

# of Institutions
231
Shares Held
86M
Call Options Held
260K
Put Options Held
387K
View Full List

About Legend Biotech Corp

LEGN Quotes by TradingView
  • Ticker LEGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 167,403,008
  • Market Cap $6.49B
  • Description
  • Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...
More about LEGN
Track This Portfolio

Track E. Ohman J:Or Asset Management Ab Portfolio

Follow E. Ohman J:Or Asset Management Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of E. Ohman J:Or Asset Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on E. Ohman J:Or Asset Management Ab with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email